Recent News

By Category: Countermeasures

Phase I Clinical Trial For An H5N1 Bird Flu Vaccine Shows Positive Results – Big News Network.com

Phase I Clinical Trial For An H5N1 Bird Flu Vaccine Shows Positive ResultsBig News Network.comIDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical …

April 22, 2013
| Filed under Countermeasures
Share

Inovio’s Universal H1N1 Influenza Vaccine Phase I Results

(GlobalBiodefense) Inovio Pharmaceuticals, Inc. announced today that its universal H1N1 influenza vaccine, designed to protect against a spectrum of viral strains, generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.

April 19, 2013
| Filed under North America and Countermeasures
Share

Inovio’s Universal H1N1 Influenza Vaccine Phase I Results

Inovio Pharmaceuticals, Inc. announced today that its universal H1N1 influenza vaccine, designed to protect against a spectrum of viral strains, generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain. The current … Continue reading →

April 18, 2013
| Filed under Countermeasures
Share

U.S. Buys More Smallpox Vaccine

(GlobalSecurityNewswire) The U.S. Health and Human Services Department has ordered another 8 million doses of the smallpox vaccine Imvamune from manufacturer Bavarian Nordic, the Danish biotechnology company announced on Tuesday. “With this order, the U.S. government will continue to maintain the stockpile of Imvamune for use in case of a public health emergency. Furthermore, the Read More »

April 17, 2013
| Filed under North America and Countermeasures
Share

U.S. Buys More Smallpox Vaccine

The U.S. Health and Human Services Department has ordered another 8 million doses of the smallpox vaccine Imvamune from manufacturer Bavarian Nordic, the Danish biotechnology company announced on Tuesday. "With this order, the U.S. government will continue to maintain the stockpile of Imvamune for use in case of a public health emergency. Furthermore, the order Read More »